Company profile

AreteMedical company profile

AreteMedical is enabling early intervention and precision management of asthma, COPD, and other chronic lung disease. We do this with a patented platform, which for the first time unites the two key data types for these diseases: inflammation and airflow mechanics. This platform will let specialist-grade data be available in primary care, then at home for people with severe/unstable disease. Our vision is to be for asthma, the equivalent that CGM is for diabetes.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
00001-00010 employees
Revenue range
$1K+
Founded
2017-07-07

Headquarters

Headquarters
Cambridge, England, United Kingdom
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
5
Last funding
Non Equity Assistance / 2025-06-02
Investors
4
Lead investors
4
Founders
1
Articles
3

Founders and investors

Founders

Graeham Douglas

Lead investors

Central London Community Healthcare NHS TrustEureka NetworkInnovate UKMassChallenge

Investors

Central London Community Healthcare NHS TrustEureka NetworkInnovate UKMassChallenge

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.